Five Female Investors Who Are Making Their Mark in Life Science 

Published on :

Five Female Investors Who Are Making Their Mark in Life Science  November 26, 2019 Less than 10% of decision-makers at U.S. venture capital (VC) firms are women and a whopping 74% of U.S. VC firms have no female investors at all, according to TechCrunch. While the number of female VC decision-makers has increased over the [….]

If You Want to Raise Venture Capital These are Two Often Overlooked Factors That Investors Want to See

Published on :

If You Want to Raise Venture Capital These are Two Often Overlooked Factors That Investors Want to See November 12, 2019 If you are an entrepreneur, there is no better place to sharpen your pitch, gain valuable connections and learn from veteran business leaders and investors than the annual Entrepreneur Expo hosted by the Maryland [….]

JLABS @ Washington, DC | Meet with Johnson & Johnson Innovation

Published on :

Representatives from Johnson & Johnson Innovation will provide an overview of goals and mission, highlighting how Johnson & Johnson Innovation interacts with the entrepreneurial community through JLABS, JJDC, The Innovation Centers and Janssen Business & Development.

Bio Innovation Conference

Published on :

Presented by Maryland Life Sciences (MDLS), a division of the Maryland Tech Council, the Bio Innovation Conference showcases Maryland’s innovation and success in the life sciences industry. The Bio Innovation Conference will connect more than 300 top life sciences professionals in the region with leading global brands, venture capitalists and promising startups, while embracing the [….]

Investment Conference Seeks to Expand Venture Capital Access in Biohealth Capital Region

Published on :

Investment Conference Seeks to Expand Venture Capital Access in Biohealth Capital Region Second annual Biohealth Capital Region Investment Conference set to connect emerging biohealth companies and investors seeking quality deals October 1, 2019 The second annual BHCR Investment Conference, which is an invitation-only event, will be held at AstraZeneca in Gaithersburg on October 15 and [….]

Viela Bio Becomes Latest Biotech Intent on Going Public with $150M Offering

Published on :

Viela Bio Becomes Latest Biotech Intent on Going Public with $150M Offering AstraZeneca spinout files for IPO on Nasdaq August 29, 2019 Viela Bio, the AstraZeneca spin-off biotech, has captured the attention of industry insiders since their $250M Series A investment that launched the company in 2018 and they are continuing to do becoming the [….]